Copyright
©The Author(s) 2020.
World J Meta-Anal. Apr 28, 2020; 8(2): 54-66
Published online Apr 28, 2020. doi: 10.13105/wjma.v8.i2.54
Published online Apr 28, 2020. doi: 10.13105/wjma.v8.i2.54
Classes | Adverse effects | Ref. |
Aminosalicylates | Mesalazine-nephrotoxicity and pancreatitis; sulfasalazine-blood dyscrasias | [10,11] |
Antibiotics | Photosensitivity, tendonitis, tendon rupture, cartilage growth inhibition in fetuses and children oral candidiasis, gastrointestinal disorders, peripheral neuropathy | [14-16] |
Corticosteroids | Acne, moon face and edema, sleep and mood disorders. Posterior subcapsular cataract, osteoporosis, myopathy, and susceptibility to infection. Acute adrenal insufficiency, arthralgia, increased intracranial pressure and pseudo-rheumatism syndrome | [7,20-22] |
anti-TNF | Septicemia | [28] |
Thiopurine | Hepatotoxicity, gastric intolerance and pancreatitis | [32] |
Methotrexate | Nausea, vomiting and diarrhea | [34] |
Probiotic | Clinical activity in IBD | Ref. |
Escherichia coli Nissle 1917 | Induction and maintenance of UC remission | [16,57,58,62] |
VSL#3 | Induction and maintenance of UC remission; prevention of relapses in chronic pouchitis | [65,66,68,69] |
Saccharomyces boulardii | Clinical remission of UC | [68-70] |
Bifidobacterium longum | Objective improvements in UC parameters | [71] |
Lactobacillus acidophilus La-5 + Bifidobacterium BB-12 | Probable improvement of intestinal parameters in IBD | [72] |
- Citation: Silva NOE, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Probiotics in inflammatory bowel disease: Does it work? World J Meta-Anal 2020; 8(2): 54-66
- URL: https://www.wjgnet.com/2308-3840/full/v8/i2/54.htm
- DOI: https://dx.doi.org/10.13105/wjma.v8.i2.54